2Nathan RA, Sorkness CA, Kosinsk Im, et al Development of the asthma a control test a survey for assessing asthma a control JA llergy[J]. Clin lmmunol,2004,113 ( 1 ) :59 -65.
2Pauwels RA, Pedersen S, Busse WW, et al. START Investigation Group. Early intervention with budesonide in mild persistent asthma : a randomized, double blind trial. Lancet, 2003,361 : 1071 - 1076.
3OByrne PM, Bisgard H, Gohart PP, et al. Budesonide/Formoterol combination Therapy as Both Maintenance and Reliever Medication in Asthma. Am J Respir Crit Care Med,2004,171 : 129 - 136.
4Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budenoside on exacerbation of asthma: Formoterol And Corticosteroids Establishing Therapy [ FACET ] International study Group. N Eng J Med, 1997,337 : 1405 - 1411.
5OByrne PM, Barnes PJ, Rudriguoz-Rosin R, et al. Tow dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med,2001,164: 1392 - 1397.
6Bateman ED, Bousley HA, Bousquet J, et al. Can Guideline-defined Asthma Control be achieved. The Gaining Optimal Asthma Control Study (GOAL). Am J Respir Crit Care Med,2004,170: 836 - 844.
7Fitz Gerald JM, Boulet LP, Richard MA. The CONCEPT Trial: A 1-year multicenter, Randomized, Double-blind, Double-Dummy comparison of a stable dosing Regimen of Formoterol/Budesonide in Adult with persistent Asthma. Clin Ther,2003,27 (4) :393 - 406.
8Nelson HS, Weiss ST, Bleecker ER, et al. The SMART Study Group. The Salmeterol Muhicenter Asthma Research Trial. Chest, 2006,129 : 15 - 26.
10Virchow JC, Crompton GK, Dal Negro R, et al. Importance of inhaler devices in the management of airway disease[ J]. Respiratory Medi-eine,2008,102 ( 1 ) :10 - 19.
